MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics Inc. (APVO)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
-$4,728K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Prepaid expenses and other curre...
Accounts payable
Others
Negative Cash Flow Breakdown
Net loss
Operating lease liability
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-6,356
-6,697
-5,806
-7,549
Stock-based compensation
58
57
2
77
Non-cash lease expense
270
271
1,089
-
Depreciation and amortization
32
35
81
49
Prepaid expenses and other current assets
-457
-3
-126
-83
Operating lease right-of-use asset
-
-
-
148
Accounts payable
272
13
-
-
Accounts payable, accrued compensation, accrued expenses and other current liabilities, and short-term operating lease
-
-
434
724
Accrued expenses and other current liabilities
157
-1,303
-
-
Long-term operating lease liability
-
-
-
-220
Operating lease liability
-344
-344
-1,376
-
Net cash used in operating activities
-5,454
-7,965
-5,236
-6,688
Net cash from investing activities
0
0
0
-
Value of equity awards withheld for tax liability
-
-
0
-
Proceeds from exercise of common warrants, net of issuance costs
-
-
557
-
Proceeds from issuance of common stock and pre-funded warrants exercise, net of issuance costs
726
872
37,940
-
Proceeds from issuance of common stock, pre-funded warrants exercise, and common warrants exercise, net of issuance costs
-
-
-
32,703
Payments in lieu of fractional shares
0
1
-
-
Net cash provided by financing activities
726
871
5,794
18,339
Increase (decrease) in cash and cash equivalents
-4,728
-7,094
558
11,651
Cash and cash equivalents at beginning of period
14,525
21,619
21,061
8,714
Cash and cash equivalents at end of period
9,797
14,525
21,619
21,061
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
APVO Cash Flow Sankey Diagram
Sankey diagram visualizing APVO cash flow for the period
Proceeds from issuance of
common stock and...
$726K
(-94.95%↓ Y/Y)
Net cash provided by
financing activities
$726K
(-94.95%↓ Y/Y)
Increase (decrease) in
cash and cash...
-$4,728K
(-779.31%↓ Y/Y)
Canceled cashflow
$726K
Prepaid expenses and
other current assets
-$457K
(-66.79%↓ Y/Y)
Accounts payable
$272K
Non-cash lease expense
$270K
Accrued expenses and
other current...
$157K
Stock-based compensation
$58K
(241.18%↑ Y/Y)
Depreciation and
amortization
$32K
(-70.91%↓ Y/Y)
Net cash used in
operating activities
-$5,454K
(60.10%↑ Y/Y)
Canceled cashflow
$1,246K
Net loss
-$6,356K
(49.60%↑ Y/Y)
Operating lease liability
-$344K
Buy us a coffee